4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-016248
Director acquired 4,793 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOWEN MAXINE Director | 2025-06-06 | Option exercise | +4,793 | 21,754 | D | ||
| Derivatives | |||||||
| GOWEN MAXINE Director | 2025-06-05 | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | D | ||
| GOWEN MAXINE Director | 2025-06-05 | Grant or award · Restricted Stock Units | +11,580 | 11,580 | D | ||
| GOWEN MAXINE Director | 2025-06-06 | Option exercise · Restricted Stock Units | −4,793 | 0 | D | ||
Loading xslF345X05/form4-06092025_040604.xml…